HK1209116A1 - 6-((s)-1-1-[5-(2-hydroxy-ethoxy)-pyridin-2-yl]-1h-pyrazol-3-yl- ethyl)-3h-1,3-benzothiazol-2-one as a tarp-gamma 8 dependent ampa receptor antagonist tarp-8 ampa 6-((s)-1-1-[5-(2--)- -2-]-1h--3--)-3h-13--2- - Google Patents

6-((s)-1-1-[5-(2-hydroxy-ethoxy)-pyridin-2-yl]-1h-pyrazol-3-yl- ethyl)-3h-1,3-benzothiazol-2-one as a tarp-gamma 8 dependent ampa receptor antagonist tarp-8 ampa 6-((s)-1-1-[5-(2--)- -2-]-1h--3--)-3h-13--2-

Info

Publication number
HK1209116A1
HK1209116A1 HK15109825.5A HK15109825A HK1209116A1 HK 1209116 A1 HK1209116 A1 HK 1209116A1 HK 15109825 A HK15109825 A HK 15109825A HK 1209116 A1 HK1209116 A1 HK 1209116A1
Authority
HK
Hong Kong
Prior art keywords
tarp
ampa
benzothiazol
pyrazol
pyridin
Prior art date
Application number
HK15109825.5A
Other languages
English (en)
Chinese (zh)
Inventor
Jon Kevin Reel
Warren Jaye Porter
Jeffrey Michael Witkin
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of HK1209116A1 publication Critical patent/HK1209116A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK15109825.5A 2012-11-27 2015-10-08 6-((s)-1-1-[5-(2-hydroxy-ethoxy)-pyridin-2-yl]-1h-pyrazol-3-yl- ethyl)-3h-1,3-benzothiazol-2-one as a tarp-gamma 8 dependent ampa receptor antagonist tarp-8 ampa 6-((s)-1-1-[5-(2--)- -2-]-1h--3--)-3h-13--2- HK1209116A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261730273P 2012-11-27 2012-11-27
PCT/US2013/070885 WO2014085153A1 (en) 2012-11-27 2013-11-20 6-((s)-1-{1-[5-(2-hydroxy-ethoxy)-pyridin-2-yl]-1h-pyrazol-3-yl}- ethyl)-3h-1,3-benzothiazol-2-one as a tarp-gamma 8 dependent ampa receptor antagonist

Publications (1)

Publication Number Publication Date
HK1209116A1 true HK1209116A1 (en) 2016-03-24

Family

ID=49753484

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15109825.5A HK1209116A1 (en) 2012-11-27 2015-10-08 6-((s)-1-1-[5-(2-hydroxy-ethoxy)-pyridin-2-yl]-1h-pyrazol-3-yl- ethyl)-3h-1,3-benzothiazol-2-one as a tarp-gamma 8 dependent ampa receptor antagonist tarp-8 ampa 6-((s)-1-1-[5-(2--)- -2-]-1h--3--)-3h-13--2-

Country Status (36)

Country Link
US (1) US8765960B2 (ru)
EP (1) EP2925754B1 (ru)
JP (1) JP6246227B2 (ru)
KR (1) KR101693133B1 (ru)
CN (1) CN104797578B (ru)
AP (1) AP2015008489A0 (ru)
AR (1) AR093527A1 (ru)
AU (1) AU2013352594B2 (ru)
BR (1) BR112015011200A2 (ru)
CA (1) CA2889243C (ru)
CL (1) CL2015001419A1 (ru)
CR (1) CR20150267A (ru)
CY (1) CY1118657T1 (ru)
DK (1) DK2925754T3 (ru)
DO (1) DOP2015000113A (ru)
EA (1) EA026686B1 (ru)
ES (1) ES2618260T3 (ru)
HK (1) HK1209116A1 (ru)
HR (1) HRP20170274T1 (ru)
HU (1) HUE033447T2 (ru)
IL (1) IL238831B (ru)
JO (1) JO3225B1 (ru)
MA (1) MA38126B1 (ru)
MX (1) MX356478B (ru)
MY (1) MY177721A (ru)
PE (1) PE20151728A1 (ru)
PH (1) PH12015501154B1 (ru)
PL (1) PL2925754T3 (ru)
PT (1) PT2925754T (ru)
SG (1) SG11201504164VA (ru)
SI (1) SI2925754T1 (ru)
TN (1) TN2015000200A1 (ru)
TW (2) TW201825484A (ru)
UA (1) UA114345C2 (ru)
WO (1) WO2014085153A1 (ru)
ZA (1) ZA201503733B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201609719A (zh) * 2014-05-28 2016-03-16 美國禮來大藥廠 作為ＴＡＲＰ－γ８依賴性ＡＭＰＡ受體拮抗劑之６－經取代－３Ｈ－１，３－苯并噻唑－２－酮化合物
ES2767707T3 (es) 2015-04-29 2020-06-18 Janssen Pharmaceutica Nv Compuestos de indolona y su uso como moduladores de receptor AMPA
EP3288936B1 (en) 2015-04-29 2020-05-06 Janssen Pharmaceutica NV Benzimidazolone and benzothiazolone compounds and their use as ampa receptor modulators
SG11201708190UA (en) * 2015-04-29 2017-11-29 Janssen Pharmaceutica Nv Azabenzimidazoles and their use as ampa receptor modulators
BR112017023038A2 (pt) 2015-04-29 2018-07-03 Janssen Pharmaceutica Nv imidazopirazinas e pirazolopirimidinas e seu uso como moduladores do receptor ampa
CN109963851B (zh) * 2016-10-26 2021-11-30 詹森药业有限公司 融合的双环吡啶化合物及其作为ampa受体调节剂的用途
RU2650523C1 (ru) * 2017-07-24 2018-04-16 федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) Производное пиридоксина для лечения эпилепсии
RU2703286C1 (ru) * 2019-06-18 2019-10-16 федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) Соли (5-гидрокси-3,4-бис(гидроксиметил)-6-метилпиридин-2-ил)метансульфокислоты и способ их получения

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY132385A (en) * 1995-08-31 2007-10-31 Novartis Ag 2,3-dioxo-1,2,3,4-tetrahydro-quinoxalinyl derivatives
JP2000281676A (ja) * 1999-01-25 2000-10-10 Yamanouchi Pharmaceut Co Ltd Ａｍｐａ拮抗化合物の新規製造法
PT1300396E (pt) * 2000-06-12 2009-04-20 Eisai R&D Man Co Ltd Compostos de 1,2-di-hidropiridina, processos para a sua preparação e sua utilização
US8995993B2 (en) * 2000-10-11 2015-03-31 Gogo Llc System for managing mobile internet protocol addresses in an airborne wireless cellular network
CA2589678A1 (en) * 2004-12-17 2006-06-22 Eli Lilly And Company Novel mch receptor antagonists
WO2007076161A2 (en) 2005-12-27 2007-07-05 Myriad Genetics, Inc Compounds with therapeutic activity
TW200817385A (en) * 2006-07-04 2008-04-16 Organon Nv Heterocyclic derivatives
US20110178165A1 (en) * 2008-10-08 2011-07-21 Pfizer Inc. Tetrahydrofuranyl sulfonamides and pharmaceutical compositions thereof
HUE025013T2 (hu) * 2009-01-12 2016-04-28 Pfizer Ltd Szulfonamid-származékok
EP2576544A4 (en) * 2010-06-01 2013-09-11 Angion Biomedica Corp INHIBITORS OF CYTOCHROMES P450 AND USES THEREOF
US9527807B2 (en) * 2011-04-05 2016-12-27 Takeda Pharmaceutical Company Limited Sulfonamide derivative and use thereof
TW201609719A (zh) 2014-05-28 2016-03-16 美國禮來大藥廠 作為ＴＡＲＰ－γ８依賴性ＡＭＰＡ受體拮抗劑之６－經取代－３Ｈ－１，３－苯并噻唑－２－酮化合物

Also Published As

Publication number Publication date
WO2014085153A1 (en) 2014-06-05
SI2925754T1 (sl) 2017-02-28
JO3225B1 (ar) 2018-03-08
CR20150267A (es) 2015-09-16
MA38126A1 (fr) 2017-03-31
PH12015501154A1 (en) 2015-08-10
HUE033447T2 (en) 2017-11-28
WO2014085153A8 (en) 2014-07-31
PT2925754T (pt) 2017-02-27
US8765960B2 (en) 2014-07-01
TW201825484A (zh) 2018-07-16
SG11201504164VA (en) 2015-07-30
KR20150070401A (ko) 2015-06-24
EP2925754A1 (en) 2015-10-07
AR093527A1 (es) 2015-06-10
UA114345C2 (uk) 2017-05-25
MY177721A (en) 2020-09-23
AU2013352594B2 (en) 2016-02-18
CN104797578A (zh) 2015-07-22
AU2013352594A1 (en) 2015-06-04
DK2925754T3 (en) 2017-02-20
CA2889243C (en) 2017-06-13
IL238831A0 (en) 2015-06-30
TW201434834A (zh) 2014-09-16
CA2889243A1 (en) 2014-06-05
JP6246227B2 (ja) 2017-12-13
IL238831B (en) 2018-08-30
KR101693133B1 (ko) 2017-01-04
US20140148441A1 (en) 2014-05-29
AP2015008489A0 (en) 2015-05-31
MA38126B1 (fr) 2017-11-30
CL2015001419A1 (es) 2015-10-02
DOP2015000113A (es) 2015-06-15
PH12015501154B1 (en) 2015-08-10
TN2015000200A1 (en) 2016-10-03
ZA201503733B (en) 2017-09-27
BR112015011200A2 (pt) 2017-07-11
HRP20170274T1 (hr) 2017-04-07
EA026686B1 (ru) 2017-05-31
CN104797578B (zh) 2016-11-23
JP2016501219A (ja) 2016-01-18
TWI618705B (zh) 2018-03-21
MX356478B (es) 2018-05-30
PE20151728A1 (es) 2015-12-02
ES2618260T3 (es) 2017-06-21
EP2925754B1 (en) 2016-12-28
EA201590823A1 (ru) 2015-08-31
PL2925754T3 (pl) 2017-07-31
MX2015006697A (es) 2015-08-05
CY1118657T1 (el) 2017-07-12

Similar Documents

Publication Publication Date Title
HK1209116A1 (en) 6-((s)-1-1-[5-(2-hydroxy-ethoxy)-pyridin-2-yl]-1h-pyrazol-3-yl- ethyl)-3h-1,3-benzothiazol-2-one as a tarp-gamma 8 dependent ampa receptor antagonist tarp-8 ampa 6-((s)-1-1-[5-(2--)- -2-]-1h--3--)-3h-13--2-
HRP20190361T1 (hr) Derivati triazolo[4,5-d]pirimidina kao antagonisti cb2 receptora
EP2768305A4 (en) 2,5-DISUBSTITUTED THIOMORPHOLIN OREXINE RECEPTOR ANTAGONISTS
PL3686194T3 (pl) Związki 2-(2,4,5-podstawione-anilino)pirymidynowe
EP2935214A4 (en) 1,4-PYRIDONES COMPOUNDS
HK1198535A1 (en) 5-(3-aminophenyl)-5-alkyl-5,6-dihydro-2h-[1,4] oxazin-3-amine derivatives 5-(3-)-5--5,6--2h-[1,4]-3-
SI2862860T1 (sl) Spojine 1,3-oksazolidina ali 1,3-oksazinana kot antagonisti receptorja oreksina
PT2912030T (pt) Processo melhorado de fabrico de 5-(2,6-di-4-morfolinil-4- pirimidinil)-4-trifluorometilpiridin-2-amina
EP3038466A4 (en) 2,2-difluorodioxolo a2a receptor antagonists
EP2846801A4 (en) CGRP RECEPTOR ANTAGONISTS BASED ON PYRIDINE
HK1180955A1 (en) Heterocyclyl compounds as histamine h3 receptor ligands h3
ZA201307840B (en) 5-membered ring heteroaromatic derivatives having npy y5 receptor antagonistic activity
IL230334A0 (en) Non-competitive nicotinic receptor antagonists

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20201118